mGluR5, which is mainly located at the postsynaptic regions (49), is an important regulator of both excitatory and inhibitory pathways, and alterations in its expression are often related to a number of neurological and psychiatric conditions, including epilepsy, anxiety, and autism spectrum disorder (ASD) (50). The gene discussed is GRM5; the disease is epilepsy.